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Abstract
Background: Research in type 1 diabetes management has increased exponentially since the irruption of mobile health apps
for its remote and self-management. Despite this fact, the features affect in the disease management and patient empowerment
are adopted by app makers and provided to the general population remain unexplored.
Objective: To study the gap between literature and available apps for type 1 diabetes self-management and patient empowerment
and to discover the features that an ideal app should provide to people with diabetes.
Methods: The methodology comprises systematic reviews in the scientific literature and app marketplaces. We included articles
describing interventions that demonstrated an effect on diabetes management with particular clinical endpoints through the use
of mobile technologies. The features of these apps were gathered in a taxonomy of what an ideal app should look like to then
assess which of these features are available in the market.
Results: The literature search resulted in 231 matches. Of these, 55 met the inclusion criteria. A taxonomy featuring 3 levels
of characteristics was designed based on 5 papers which were selected for the synthesis. Level 1 includes 10 general features
(Personalization, Family support, Agenda, Data record, Insulin bolus calculator, Data management, Interaction, Tips and support,
Reminders, and Rewards) Level 2 and Level 3 included features providing a descriptive detail of Level 1 features. Eighty apps
matching the inclusion criteria were analyzed. None of the assessed apps fulfilled the features of the taxonomy of an ideal app.
Personalization (70/80, 87.5%) and Data record (64/80, 80.0%) were the 2 top prevalent features, whereas Agenda (5/80, 6.3%)
and Rewards (3/80, 3.8%) where the less predominant. The operating system was not associated with the number of features
(P=.42, F=.81) nor the type of feature (P=.20, χ2=11.7). Apps were classified according to the number of level 1 features and
sorted into quartiles. First quartile apps had a regular distribution of the ten features in the taxonomy whereas the other 3 quartiles
had an irregular distribution.
Conclusions: There are significant gaps between research and the market in mobile health for type 1 diabetes management.
While the literature focuses on aspects related to gamification, rewarding, and social communities, the available apps are focused
on disease management aspects such as data record and appointments. Personalized and tailored empowerment features should
be included in commercial apps for large-scale assessment of potential in the self-management of the disease.
(JMIR Mhealth Uhealth 2018;6(11):e12237)   doi:10.2196/12237
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Introduction
Diabetes mellitus is a metabolic syndrome, which comprises
an impaired insulin production and action [1]. Type 1 diabetes
mellitus (T1DM) prevalence is rapidly rising throughout the
world [2]. Supporting T1DM patients is a major health care
challenge, as it involves many aspects of daily routine activities
(eg, food intake, physical activity, motivation) and specific
knowledge of disease mechanisms (eg, blood glucose regulation,
insulin intake) [3,4].
Despite the promise of mobile health (mHealth) in the specific
field of diabetes [5,6] and the explosion of diabetes-related apps
in markets, T1DM management is yet undertaken on a routine
care basis, in which glycemic levels (blood glucose and
hemoglobin A1c (HbA1c) among others) and other health-related
outcomes are supervised by general practitioners,
endocrinologists, and nurses. This type of care has shown limited
effects on empowering patients to control blood sugar levels
[7].
In their review from 2011, Chomutare et al [8] compared the
recommendations from evidence-based guidelines and the
features of mobile apps. The evaluation of features was analyzed
for 6 types of functionalities: (1) self-monitoring, (2) education,
(3) alerts, (4) reminders, (5) social media, and (6) personal health
records synchronization. The authors concluded that apps did
not include education structural elements from the empowerment
of patients other than including functionalities for routine
management (record of lifestyle and measurements). The lack
of core recommendations compromised the effectiveness of
mobile health in diabetes clinical management [9].
Since then, several studies have been conducted to test the
effectiveness of apps in reduced samples of patients. In such
studies, researchers evaluate apps with different approaches and
patient groups, yielding conflicting conclusions due to the
different methodology of the interventions [10].
This study aimed to assess whether app manufacturers adopted
the findings from mHealth evidence-based interventions in
diabetes. The rationale is to mind the gap between research and
the market to identify the features that are not available in
commercial apps. The methodology comprises 2 systematic
reviews using the PRISMA methodology, one in the scientific
literature (without meta-analysis) and the other in app
marketplaces. The systematic review of scientific literature is
focused on interventions with apps on patients with T1DM into
randomized controlled trials (RCTs). In the first stage, we built
the schema of what could be an ideal diabetes app (including
all the features which have shown a positive effect on diabetes
management) and to then analyze the characteristics of available
apps and their distance to the ideal app.
Methods
Selection Criteria
The primary objective of this study was to review scientific
literature using the PRISMA methodology to enumerate
evidence-based features that have demonstrated a positive effect
in the management of T1DM in RCTs. Inclusion criteria were
defined as (1) a mHealth intervention on T1DM patients using
an app for remote and self-management of the disease and (2)
the intervention was performed in an RCT and reports on clinical
outcomes (HbA1c, in-range time or self-monitoring blood
glucose). Exclusion criteria included (1) gray literature, (2)
studies not reporting RCTs on T1DM (eg, type 2 diabetes,
gestational diabetes), and (3) studies not using an app (eg, text
messages, manual notes) or not describing the app’s
functionality. The secondary objective was to compare the
evidence-based features with the characteristics of the available
apps.
Recruitment Strategy
The source of the literature review were online journal databases
and indexers (PubMed, Medline, Google Scholar, and Cochrane
Trials). We searched a combination of keywords including type
1 diabetes mellitus, mobile health, RCTs and self-management.
The complete search strategy, combination of keywords in the
queries and results for PubMed are described in Multimedia
Appendix 1. The search included all the parts of the manuscript
(title, abstract, keywords, and text). The review was conducted
in July 2018, and we focused our review on recently published
papers (January 2012-July 2018). Only publications in English
were considered for inclusion.
Subsequently, the approach for recruiting apps was twofold.
First, a web search was conducted by using keywords of 3
different groups: (1) “diabetes mellitus 1 AND apps AND
(android OR iPhone) AND self-management,” (2) “diabetes
mellitus,” and (3) “diabetes apps AND self-management.” A
second search was conducted in Google Play and the App Store
to recruit a greater number of apps. In this case, we introduced
2 keywords: “diabetes AND management.” After collecting all
the available apps, the screening and selection were done in the
same way as with the publications (using a PRISMA flow
diagram). Subsequently, the selected apps were downloaded
and tested to know which of the characteristics obtained with
the systematic literature review were available in the apps.
Data from the literature review and the apps assessment was
extracted by 2 of the authors (AMM and EJP) using a structured
data form. For the literature review, we extracted data related
to the study (year of publication, sample size, the age of
participants, methodology, intervention, clinical endpoints,
features, usability, and satisfaction). Studies were assessed using
the Cochrane Collaboration’s tool to assess the risk of bias of
included (selection, reporting, performance, and attrition) [11].
For the app review, we extracted the type of features each app
offered, the operative system, language, icon, and link.
Statistical Analysis
A descriptive analysis of the features in the apps was done
before association analytics. Association of the type of features
and the type of operative system was evaluated with a two-way
analysis of variance, in which we assessed the P value and the
F statistic. Association of the number of features and the
operative system was assessed using Kruskal-Wallis tests at
95% CI, in which we calculated the P value and the chi-square
value. A value of P<.05 was considered as significant The
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Feature Factor (FF) was defined as the polynomial formula
(Equation 1) FF= NL1
3+NL2
2+NL3 where NLx is the number of
features in level 1, level 2, and level 3 respectively. We used
MATLAB 2017Ra framework under Academic License to
conduct the statistical analysis.
Results
Systematic Literature Review of Features
Figure 1 shows the cascade flow of search process for the
literature review. A total of 449 scientific publications were
found in the selected search engines with the chosen keywords
and the date constraints. After excluding 216 duplicated entries,
we obtained a total of 233 original publications. In the second
screening of these 233 articles, 176 were not related to the
objective of this study and were eliminated. A big part of the
remaining 51 articles was not matching the inclusion criteria.
Ten of the 51 (19.6%) did not refer to T1DM, 5/51 (9.8%) were
not related to mHealth, 11/51 (21.6%) were reviews, 17/51
(33.3%) were not in the scope of our study, 3/51 (5.9%) did not
allow full-text publication accessibility, and 5/51 (9.8%) did
not provide relevant data for the synthesis. Finally, once read
and analyzed, 6/57 (11.8%) scientific publications were included
for the synthesis [12-17].
These 6 studies reported on the results evaluating the benefits
of apps in the management of T1DM (Table 1). These studies
consisted of 266 participants (as we only considered intervention
groups) in RCTs and lasted from 3 to 12 months. Only studies
with a clear clinical endpoint were considered (eg, HbA1c
improvement, self-monitoring blood glucose (SMBG) daily
rate).
Figure 1. Selection of the literature for evidence-based features of mobile apps for type 1 diabetes management and empowerment.
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Table 1. Characteristics of the studies evaluating mobile apps for type 1 diabetes mellitus management and empowerment.
Ryan [17]Clemens [16]Kirwan [15]Goyal [14]Cafazzo [13]Castensøe-Seiden-
faden [12]
Characteristics
201720172013201720122018Publication year
188125462076Intervention, n
40 (13.9)14.0 (10.4-15.9)a35.9 (10.6)14.1 (1.7)14.9 (1.3)17.6 (2.6)Age (years), mean
(SD)
27.3 (14.9)4.9 (2.7-7.5)a19.7 (9.6)7.1 (3.2)NSc8.0 (4.5)Timeb (years), mean
(SD)
43.6612312Duration (months)
Usual care AppRetrospective anal-
ysis
App FeedbackUsual care AppAppUsual care AppIntervention type
NSNSGlucose BuddyBantBantYoung with Dia-
betes
App name
Decrease in medi-
an (9.1% to 7.8%)
No significant
change
Decrease in mean
(SD) from 9.08%
(1.18%) to 7.8%
(0.75%)
Decrease by 0.58%
(P=.02)
No significant
change
No significant
change
HbA1c
d outcome
—Increased 2.3 timesNo significant
change
—Increased mean
daily frequency
(2.4 to 3.6, P=.006,
n=12)
—SMBGe outcome
Bolus
calculator and glu-
cose control.
Badges used by
17%
Data synchroniza-
tion
NAg; texting exten-
sively used
Trending feature,
logbook, and home
menu (statistics)
Reminders, blood
glucose regulation,
insulin and food
regulation, emer-
gency readiness,
exercise
Chat Room
(among young
people)
App perceived useful-
nessf
NANANA76% “satis-
fied/very satisfied”
96% would contin-
ue using app
88% would contin-
ue to use
>80% would rec-
ommend
User satisfaction
aMedian and interquartile range.
bSince diagnosis.
cNS: not specified.
dHbA1c: hemoglobin A1c.
eSMBG: self-monitoring blood glucose.
fEither a 5-point or 10-point Likert scale was used to score.
gNA: not assessed.
Overall, the included trials adequately achieved a low level of
risk of bias (Table 2). Three of the studies did not report on
random sequence generation, and 2 did not adequately report
concealing the allocation sequence to determine if the group
could have been foreseen. Only 2 trials blinded the outcome
assessment. Besides, all trials except 1 adequately described
data completeness (including exclusion and drops out) and did
not perform selective outcome description.
The majority of these studies assessed the features of the app
which had a higher perceived usefulness or a good adoption
among study subjects. Castensøe-Seidenfaden et al [12] found
the Chat Room as the most rated feature, a virtual space for user
communication in which users posted comments about alcohol
and sex. Cafazzo et al [13] report the user-centered design and
evaluation in 12 subjects of the Bant app; a mobile app that’s
focused on the simple and automated transfer of glucometer
readings, a social community and rewards for healthy behavior
adherence (average 8 rewards per user in a three-month trial).
An updated version of the Bant app was tested by Goyal et al
[14] in a 12-months trial involving 46 subjects, pointing out the
trends, logbook, and homepage as the preferred features of the
app. Kirwan et al [15] examined the effectiveness of Glucose
Buddy, a free app combined with texting from a certified
diabetes educator in 25 subjects.
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Table 2. Cochrane Collaboration’s tool risk-of-bias assessment for the clinical outcomes (hemoglobin A1c and self-monitoring blood glucose changes)
of the included study papers.
Ryan [17]Clemens [16]Kirwan [15]Goyal [14]Cafazzo [13]Castensøe-Seidenfaden [12]
HighHighLowLowHighLowRandom sequence generation
LowHighLowLowHighLowAllocation concealment
N/AN/AN/AN/AN/AN/AaBlinding of participants and personnel
UnclearHighLowHighHighLowBlinding of outcome assessment
LowLowHighLowLowLowIncomplete outcome data
LowLowHighLowLowLowSelective reporting
LowUnclearUnclearLowUnclearLowOther bias
aN/A: not applicable (both patient and doctors know the group they are allocated).
Clemens and Staggs [16] reported a retrospective study on 81
youth T1DM patients who used a mobile app connected to a
glucose meter, showing that data synchronizations were
associated with an increased rate of SMBG but not with HbA1c
or mean glucose values. Beyond data synchronization, no more
app features were provided by authors in this paper. Finally,
Ryan et al [17] developed and evaluated Intelligent Diabetes
Management, an app for insulin bolus calculation and an
electronic diabetes diary in clinical visits. The app included a
“badge” feature for motivational accolades based on the reported
measurements. The 18 subjects, who completed the study, rated
the insulin calculator with 8 in a 10-point Likert scale and only
17% of subjects used the “badges” feature regularly.
Three of these studies evaluated the user satisfaction in terms
of willingness to use the app after the trial and willingness to
recommend its use to peers. Each showed a high percentage of
subjects willing to continue using the app and willing to
recommend the app to peers [12-14]. In our study, we analyzed
the features available in the mobile apps (rated or not) and
gathered in a hierarchical map of functionalities.
Features Taxonomy of an Ideal App
The qualitative study of the apps used in the studies allowed us
to extract the characteristics of the apps that users rated as key
and researchers considered of value. These features were sorted
into functional areas beyond the traditional 4 clinical areas of
diabetes management taxonomy (glycemic control, carbohydrate
intake, insulin and exercise) [18]. The new proposed taxonomy
(Figure 2) had 3 hierarchical levels, the first of which had 10
areas: (1) Personalization, (2) Family support, (3) Agenda, (4)
Data record, (5) Insulin bolus calculation, (6) Data management,
(7) Interaction, (8) Tips and support, (9) Reminders, and (10)
Rewards. In this area, we included all the functions and settings
that users can adjust to customize the app interface, the behavior,
and calculations (if any). The basic feature was building a user
profile for the social community of app users, with the capability
of adding a picture or avatar. The second feature in
Personalization was the possibility of configuring the blood
glucose diary (or record), adjusting personalized thresholds for
supporting the patient, and product recommendation. The third
feature was the configuration of the user mood. The fourth
feature was the self-adjustment of goals of any type (glucose
goals, carbs intake, weight loss). The fifth feature was setting
up the type of insulin, the brand, and the intake method. The
sixth feature was configuring tailored advices (eg, topic
selection, when to show the advice). The seventh feature was
the personalization of the measurements reporting, instead of
having a default form for data introduction, for all the relevant
variables (Figure 2). The last feature of personalization was the
customization of physical activity reporting.
Family support was a feature in which relatives can perform a
follow-up of the data introduced by the patient in which we
have identified read access and read-and-write access. This
feature also contains literature support for relatives in the
management of T1DM through web links and books. The
Agenda feature was a common factor in the apps analyzed in
the review, and it was mainly devoted for scheduling medical
and personal appointments. Another recurrent feature was the
storage of measurements and reports related to food intake,
insulin intake, and physical activity, which are under the Data
record feature. In this feature, we made a distinction between
the apps that had manual data entry (eg, forms, pictures, voice
recognition, avatar) and the automatic entry of data using
wireless sensors, mobile phone sensors (such as an
accelerometer for physical activity) and smartwatches and
wearables. The last feature (right side in Figure 2) was the
Insulin bolus calculator, which provided calculations for
exogenous insulin injection for fast action (bolus) or slow action
(basal), and for the insulin pump device (bolus and basal).
The Data management feature involved the capability of the
app of exporting, storing, and analyzing the data collected in
the app. In the review, one of the top-rated features was the
graphical representation of measurements and the calculation
of statistics based on these measurements. The second feature
in the right side of Figure 2 refers to the ability of the app to
interact with other subjects beyond the T1DM user (clinicians,
parents, and other app users). This interaction was generic and
involves social communities, participation in forums, and data
sharing. All the analyzed apps had a feature for Tips and support,
which involved a user manual of the app. Some of them also
included generic information related to diet and physical activity.
Only 1 had online 24/7 medical support and emergency
management. The Reminders feature enabled users to set up
alerts for measuring and recording blood glucose tests, insulin
intakes, insulin and glucometer strip purchasing, and attending
medical or personal appointments scheduled in the Agenda.
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Finally, the Reward feature contained the motivation
mechanisms that the app implements for control and therapy
adherence. Rewarding strategies in the review were related for
providing credit in virtual markets, premium access to the app
(rewards for enhanced functionalities) and other types of credit
for online stores (Amazon, eBay vouchers).
Systematic Review of Commercial Diabetes
Management Apps
We evaluated the available apps through an online search, the
App Store (Apple) and Google Play (Android) for diabetes
management and support. Following the PRISMA methodology
approach (Figure 3), we obtained 93 single apps devoted to
T1DM (20/93 (21.5%) from the online search and 73/93 (78.5%)
from the previously mentioned app markets). Five of the 93
apps (5.4%) were excluded because the links for downloading
the software were unavailable. Of the remainder, 8/87 (91.9%)
apps were excluded from the detailed analysis: 2/87 (2.3%)
because they were not tailored to T1DM, 2/87 (2.3%) because
they focused on healthcare professionals, 2/87 (2.3%) because
the access was secured with a password (corporate use), 1/87
(1.1%) because it was not free and 1 (1.1%) because it was a
copy of another app with different name and icon. Finally, 80
apps (Figure 4) were assessed to discover the extent to which
these apps fulfilled the feature schema of an ideal app taxonomy.
Android and iOS apps were tested during a month since many
apps needed control over a longer period to provide data
(graphics, statistics) to the user. A mHealth expert analyzed the
apps and collected all the features which matched the taxonomy
of the ideal diabetes management app. Features were flagged
with a Boolean value depending on whether the app provided
the analyzed feature. Occasionally, the mHealth expert was
provided with clarification to ensure that the analysis was more
precise.
Figure 2. Taxonomy of the features of an ideal app according to the evidence-based effectiveness of mobile health in diabetes support and empowerment.
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Figure 3. Selection of the available apps for type 1 diabetes management and empowerment.
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Figure 4. Apps included in the analysis. From top-down left-right: Balansio, Bant, BeatO, Beyond type 1 diabetes, Blood glucose tracker, BlueLoop,
Brook, Carbs & Cals, Center health, Checkmate diabetes, Chron, Contour diabetes, Dario, Diabetes a la carta, Diabetes & Me, Diabetes connect, Diabetes
diary, Diabetes diet and management, Diabetes digest, Diabetes evaluation, Diabetes experience day, Diabetes ID, Diabetes insight, Diabetes kit blood,
Diabetes metrics, Diabetes PA, Diabetes pal, Diabetes parent, Diabetes passport, Diabetes pilot pro, Diabetes plus, Diabetes treatment, Diabetes vue,
Diabetika, Diaguard, Diario de sangre, Diasend, DMI from zero to hero, Dnurse, Dottli, Dr. Diabetes, Easy diabetes, Glooko, Glucool diabetes, Glucosa
compañero, Glucose buddy, Glucose wiz, Uright, Glucosio, GluQUO, Health2sync, Helparound, iFora, Inrange, Insulclock, Kids and teens diabetes,
Kingfit, La diabetes M, Life in control, MedM diabetes, Meet me, Mi glucemia, Monitor de glucosa, Mumoactive, My diabetic alert, Nagbot, Neptun,
One drop, Ontrack diabetes, PredictBGL, Social diabetes, SOS diabetes, Sugar sense, Sugarmate, Track3lite.
The Gap Between Literature and Apps in Diabetes
Management
None from the 80 analyzed apps fulfilled the criteria of the
taxonomy of an ideal app. Only BlueLoop had 9 out of the 10
ideal features in level 1. Table 3 describes the distribution of
features amongst the analyzed apps. Sixteen of the 80 (19.7%)
apps were only for Android, 15/80 (18.5%) only for iOS, and
50/80 (62.7%) for both operative systems. The mean for the
number of level 1 features in the analyzed apps was 4.6 (SD
1.7) with interquartile range 3-6 and range 2-9. Based on the
taxonomy of an ideal app, the predominant category of features
was Personalization (70/80, 87.5%), followed by Data record
(64/80, 80.0%), Tips and support and Data management (60/80,
75.0%). Reminders were featured in less than a half (33/80,
40.7%), Family support in 37.5% (30/80), and Agenda in 36.3%
(29/80). Less than a third (23/80, 28.7%) featured Interaction
and 25.0% (20/80) had Insulin bolus calculation. The least
predominant feature was Rewards (3/80, 3.8%). The number
of level 1 features was not associated with the operative system
(P=.42, F=.81). In the same way, the level 1 type of feature was
not associated with the operative system (P=.20, X229=11.7).
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Table 3. Feature frequency in the reviewed diabetes management apps for the 3 hierarchy levels.
Apps containing the feature, n (%)Level hierarchy
70 (100.0)Personalization (n=70)
40 (57.1)User profile and picture
64 (91.4)Blood glucose diary
14 (20.0)Mood
33 (47.1)Goals
21 (30.0)Insulin type and dosage
8 (11.4)Tailored advice
24 (34.3)Measurements
24 (34.3)Weight
14 (20.0)Height
17 (24.3)Hemoglobin A1c
15 (21.4)Blood pressure
1 (0.1)Alcohol
6 (8.6)Age
14 (0.2)Gender
1 (0.1)Tobacco
12 (17.1)Years with type 1 diabetes mellitus
35 (50.0)Physical activity
30 (100.0)Family support (n=30)
30 (100.0)Access
8 (26.7)Read and write
22 (73.3)Read
7 (23.3)Literature
12 (40.0)Books
7 (23.3)Web pages
29 (100.0)Agenda (n=29)
29 (100.0)Appointments
64 (100.0)Data record (n=64)
62 (96.9)Manual
30 (46.9)Automatically
27 (42.2)Glucometer
17 (26.6)Mobile phone
1 (1.6)Smartwatch/wearable
20 (100.0)Insulin bolus calculation (n=20)
17 (85.0)Injection
9 (45.0)Bolus
7 (35.0)Pump
9 (45.0)Basal
60 (100.0)Data management (n=60)
34 (56.7)Export
16 (26.7)Comma-separated values
6 (10.0)Excel
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Apps containing the feature, n (%)Level hierarchy
10 (16.7)PDF
20 (33.3)Other
28 (46.7)Cloud storage
18 (30.0)Statistics
51 (85.0)Charts
23 (100.0)Interaction (n=23)
16 (69.6)Endocrinologists
14 (60.9)Parents/mentors
9 (39.1)Among users
60 (100.0)Tips and support (n=60)
46 (76.7)User manual of the app
28 (46.7)Diet/food information
7 (11.7)24/7 medical support
11 (18.3)Emergency
33 (100.0)Reminders (n=33)
33 (100.0)Blood glucose control and insulin
28 (84.8)Insulin/strips purchase
29 (87.9)Appointments
3 (100.0)Rewards (n=3)
0 (0.0)App Store/Google Play credit
3 (100.0)Inside the app
1 (33.3)Other (Amazon, eBay, etc.)
Level 2 features in Personalization were dominated by the Blood
glucose diary (64/70, 91.4%), whereas Tailored advice was only
present in 11.4% (8/70). If we look into level 3 Measurements
in Personalization, only 0.1% (1/70) of the apps included
Tobacco and Alcohol, and 17.1% (12/70) included a field for
Years of diagnosis. With regards to Family support, 100.0%
(30/30) featured Read access, and 26.7% (8/30) included Writing
access to relatives.
Fifty-one of 60 apps (85.0%) featuring Data management had
the possibility of drawing charts with the stored measurements,
and more than a half (34/60, 56.7%), offered the possibility of
data exportation in several formats. Nearly a half (28/60, 46.7%)
offered the possibility of storing data in the Cloud, and only
30.0% (18/60) had the option of calculating statistics.
Level 2 features of Tips and support showed that not all the
apps have a user manual (46/60, 76.7%), less than a half (28/60,
46.7%) provided Diet/food information, only 11.67% (7/60)
had 24/7 Medical support specific for diabetes, and 18.3%
(11/60) had Emergency support.
All the Reminders (33/33, 100%) were for blood glucose and
insulin schedule. A majority were for purchasing fungibles
(28/33, 84.8%) and Appointments (29/33, 87.9%). Three of 3
(100%) provided Rewards inside the app, and only 1/3 (33.3%)
gave Rewards in online markets.
Figure 5 shows the relationship between level 1 features and
the FF as defined in Equation 1. The size and color of the point
indicates the level of feature completeness according to the ideal
app taxonomy. The yellow point refers to the app which had 9
of the 10 level 1 features, which is surpassed by 2 apps with 8
level 1 features, but which also implement more level 2 features.
Apps were classified according to the number of level 1 features
they offered. Figure 6 shows the distribution of these features
in a quartile classification of the number of level 1 features
variable. First quartile (>75% in Figure 6) shows a regular
distribution of the features, except to Agenda and Rewards.
Second and third quartile apps (25%-75% in Figure 6) have a
heterogeneous distribution of features, with an increased
presence of Reminders, Personalization and Data management,
and a lower presence of Insulin calculation, Agenda, Family
support, and Rewards. First quartile (<25% in Figure 6) shows
fewer features (4 versus 10 in the other quartiles), which are
dominated by Family support and Tips and support features,
completed by Data record and Personalization.
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Figure 5. The relationship among the number of level 1 features and the Feature Factor.
Figure 6. Distribution of level 1 features classified according to the number of level 1 features in the apps divided into quartiles.
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Discussion
Principal Results
We conducted a systematic review to discover the features of
the apps that had shown an effect in T1DM management. We
found a big gap between research and market in the apps for
supporting and empowering T1DM patients. While research is
currently testing the effectiveness of mHealth in the
improvement of clinical outcomes related to T1DM and therapy
adherence, the characteristics of such apps are heterogeneous
and not consistently justified. The systematic search discovered
6 studies consisting of mHealth interventions on 266 participants
with a study duration ranging from 3 to 12 months. Studies
described the app and assessed the user perceived usefulness
of the app characteristics. Three of the 6 (50%) studies also
reported on user satisfaction. Features of the apps were
categorized and merged into a taxonomy of what would be an
ideal app for T1DM management and patient empowerment
(Figure 2).
The newly proposed taxonomy featured 3 hierarchical levels,
the first of which has 10 areas. Subsequent level 2 and level 3
features are embedded into level 1 features, enabling us to detail
what type of feature is offered to the app user (eg,
Personalization: setting up a user profile). Regarding the
interaction of patients and health care professionals, we
discovered apps including contact to and support from
endocrinologists and diabetes educators (Figure 2). We think
that a general practitioner should also be considered as a
reference contact point for some cases. Moreover, information
about current trends might also be of interest (eg, blood glucose
is increasing or decreasing) for patients having a continuous
blood glucose monitoring system, or by interpolating
self-reported measurements.
Moreover, this study explored systematically the features that
are present in apps available at zero cost for users on the internet
and mobile apps markets. Following the PRISMA approach,
we found 80 apps which were analyzed in detail for 30 days.
None of the assessed apps fulfilled the features of the taxonomy
of an ideal app, but 1 featured 9 characteristics (BlueLoop).
Personalization (70/80, 87.5%) and Data record (64/80, 80.0%)
were the 2 top prevalent features, whereas Rewards (3/80, 3.8%)
was the less predominant. We did not find an association on the
number of features (P=.42, F=.81) nor the type of feature (P=.20,
X229=11.7) with the app operative system. Level 2 features were
highly heterogeneous, but we highlight the Blood glucose diary
featured in 91.4% (64/70) of apps and the low rate of Tailored
advice only present in 11.4% (8/70). Level 2 features of Tips
and support showed that not all the apps included a user manual
(46/60, 76.7%), less than a half (28/60, 46.7%) provided
Diet/food information. Only 11.67% (7/60) offered 24/7 medical
support specific for diabetes, and 18.3% (11/60) offered
Emergency support. To our knowledge, this is the first
comprehensive taxonomy specific definition of features and the
first review exploring the availability of such features in
commercial apps for mHealth interventions in T1DM.
In a secondary analysis apps were classified according to the
number of level 1 features and sorted into quartiles (Figure 5).
First quartile apps had a regular distribution of the 10 features
in the taxonomy, expect Agenda and Rewards. Second and third
quartile did not follow this distribution, having a greater
frequency of Data record, Personalization, and Data
management. The fourth quartile featured Family support and
Tips and support.
Comparison with Prior Work
Patient empowerment is essential for T1DM management and
control [19]. Interventions for T1DM with mobile applications
are mainly used for managing measurements, reminders and
charting data, instead of promoting the self-management of the
disease with a comprehensive strategy of skills development.
Gamification and social communities have been observed as a
key factor for empowering patients, though in our review we
confirm these to features as a testimonial.
This research stresses the fact that there is a need to consider
the key features to be included in an app for T1DM. This
consideration is straightforward related to the ultimate objective
of the app. Is it for recording and storing measurements? Is it
for managing other aspects as the disposables or the
appointments? Is it targeted to empower the user? Is it to build
a social community? Goyal and colleagues argued that the
design of an app for T1DM young patients had to consider 3
factors: (1) relationship to technology, (2) how this relationship
might make a difference to users, and (3) considering when it
might not be a suitable mechanism to use [14]. There is a ring
to rule them all, but there should not be a T1DM app to rule
them all. Patients and relatives will experience an intense
evolution since disease onset until blood glucose control. This
means that there can be an app for each type of T1DM patient
depending on their momentum with the disease and their own
context.
The taxonomy of features was designed based on previous
clinical interventions [12-17] which have shown a clinical effect
on the management of diabetes with mHealth. However, more
evidence is needed to correlate specific improvements with the
types of features. Many studies revealed the clinical
effectiveness of diabetes management based on the definition
of the American Association of Diabetes Educators 7 Self-Care
Behaviors (AADE7) [20]. The AADE7defines 7 key areas for
conducting and effective management of diabetes: (1)
monitoring, (2) healthy eating, (3) taking medication, (4) being
active, (5) problem solving, (6) healthy coping, and (7) reducing
risks. Recently Ye et al [21] reviewed 137 apps for diabetes
management based on AADE7 guidelines, concluding that many
of the apps were designed for supporting healthy behaviors and
a few were for supporting patients at problem-solving, risk
reduction, and facing health from a holistic perspective. Our
findings support that the current apps are suited for basic
management instead of promoting the long-term empowerment
of patients.
In 2017, Holtz et al [22] reported the development of a T1DM
app with a patient-centered approach. One of the desirable app
features that the adolescents mentioned in the evaluation of this
study was to be part of a community. Although researchers and
clinicians are focusing on intervention based on social networks
and mobile apps [23], we do not see such progress when these
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apps are used for improving clinical endpoints nor in the apps
already available to users. Gamification and rewarding are the
least prevalent of the features, a reality that should encourage
researchers to design new gamification strategies to engage
T1DM patients on the importance of self-management.
Gamification and coaching techniques are also a promising
feature of mobile health apps for diabetes management. Sannino
et al [24] introduced the concept of a constant follow-up of the
patient’s performance along with continuous feedback and
reward system according to the user behavior and disease
control. Although this app was only tested in a pilot set up for
assessing usability and satisfaction, some of the features could
be introduced in future RCTs to discern which gamification
approaches fit better for each type of T1DM user.
The review of apps allowed us to conclude that level 1 features
in apps have a balanced distribution (Figure 6). However, rather
than focusing on the number of features in an app, research
should investigate which of the features contribute to achieving
goals effectively. A better understanding of the disease
mechanism and treatment effects lead to an improvement of
health outcomes [25]. This suggests that small changes in patient
environments can have more significant effects on behavior and
can be utilized in the self-management of diseases. The mHealth
solutions are a promising alternative enabling context-awareness
and personalization, but these solutions must be designed
integrating evidence-based behavioral change theoretical
foundations to be effective [26].
In this study, we have discovered Data record and
Personalization as the most prevalent features in mHealth
diabetes apps. This finding should be further explored to know
how many of these apps that also offer a dashboard for
professional management. A recent study has discovered a
decrease of the consultation time in type 2 diabetes management
by using artificial intelligence and predictive modeling [27,28],
and moreover, a review has proved these methods are being
progressively established as suitable for use in daily clinical
practice [29]. Future research should tap into the application of
these methods for supporting both T1DM patients and healthcare
professionals on the follow-up and control of this complex
disease.
Finally, for the main purpose of disease management apps,
rather than investigating the number of app features, we should
investigate what kind of features could achieve the goal
effectively. In our study, we were not able to distinguish which
feature (or combination of features) was helping patients to
achieve their goals. Acceptability and usability studies may help
to identify the features that have a higher impact on the
self-management of the disease, but further research should be
conducted to critically identify the sets of features valuable for
patients.
Limitations
A limitation of this study is the set of papers and apps selected
for the literature review and the app review. The authors may
have omitted significant contributions for both searches due to
the incompleteness of the query commands and mismatch in
the searches. We have focused our research on apps tested in
RCTs with significant clinical end-points. Authors are aware
of the relevant research done in the past and conducted in the
present in the design of T1DM apps, which do not involve
clinical endpoints nor RCTs, which may also contribute to the
taxonomy of an ideal app defined in this paper. Another
limitation is that the graphical user interface (GUI) of the apps
are not evaluated or studied. If the GUI is not appropriate, many
features might be less accessible and thus less used.
Conclusions
This study assessed the existing gap between research and
market in mobile health apps for the management of T1DM and
the empowerment of patients. The mHealth has potential to
support the management of T1DM, to catalyze the information
exchange between patients, parents, and caregivers, and to
empower and educate patients in the management of T1DM.
The current landscape of apps for T1DM does not seem to be
close to what researchers promote from RCTs and user-centered
design. A majority of the apps mainly support the collection of
measurements, and only a few of them offer a wide range of
features for a personalize self-management. Rewards and social
communities are not yet well adopted in market environments.
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